# RegenGeek

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/regengeek

- Industry: Biotechnology
- Headquarters: Shenzhen, China
- Website: www.regengeek.com
- Latest round: Series B (Dec 22, 2023)
- Investors on record: 7

## About

Based in Shenzhen, China, and established in 2021, RegenGeek is a biotechnology company that focuses on stem cell 3D standard cultivation. It was incubated by CASTD and its partners including the Chinese Academy of Sciences, Shenzhen Nanshan Hospital, and Haining Juanhu Lake International Science Park. In December 2023, the firm closed a series B funding.

RegenGeek provides products and services that include cocktail therapy, stem cell culture medium, and GMP ultra-clean workspace. The cocktail therapy can promote tissue regeneration, and can be used for soft tissue restoration, and bone arthritis. The stem cell culture medium has no serum protein, nonspecific protein, and clear chemical components. The GMP ultra-clean workspace adopts the removable modules, used for stem cell manufacturing.

## Funding rounds

- Series B, Dec 22, 2023 — Goldport Capital, Haining Talent Science and Technology Innovation Group
- Series A, Nov 29, 2022 — Zhongda Venture Capital, Goldport Capital, Shenzhen Zhongke Incubation Equity Investment Fund Management, Tai Partners, Guangzhou Expansion Investment Management
- Series A, Feb 10, 2022 — Tai Partners, Xiamen Wangchen Health Industry

## Investors

- Tai Partners (https://capitalatlas.ai/funds/tai-partners) — Series A
- Xiamen Wangchen Health Industry — Series A
- Zhongda Venture Capital (https://capitalatlas.ai/funds/zhongda-venture-capital) — Series A
- Goldport Capital (https://capitalatlas.ai/funds/goldport-capital) — Series A, Series B
- Shenzhen Zhongke Incubation Equity Investment Fund Management (https://capitalatlas.ai/funds/shenzhen-zhongke-incubation-equity-investment-fund-managemen) — Series A
- Guangzhou Expansion Investment Management — Series A
- Haining Talent Science and Technology Innovation Group — Series B